" class="no-js "lang="en-US"> Boris Johnson Archives - Medtech Alert
Wednesday, March 19, 2025

Sort by:

Date

Top Post

Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease

An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]

One Million Checks Delivered By NHS ‘One Stop Shops’

NHS ‘one stop shops’ have delivered over one million checks and tests since the rollout […]

NHS Publishes Electives Recovery Plan To Boost Capacity And Give Power To Patients

The NHS and government have today set out a blueprint to address backlogs built up during the Covid […]

Additional £5.4 Billion for NHS Covid Response Over Next Six Months

The NHS will receive an extra £5.4 billion over the next six months to support […]

Amanda Pritchard Appointed NHS Chief Executive

Amanda Pritchard has today been appointed as the new Chief Executive Officer of NHS England. […]

Researchers Behind Lifesaving Astra-Zeneca Jab Named Winners Of NHS Gong

Research teams at Oxford University who joined forces to fight coronavirus by developing a covid […]

Government Launches Covid-19 Antivirals Taskforce to Roll out Innovative Home Treatments This Autumn

A new Antivirals Taskforce has been launched by the government to identify treatments for UK […]

GSK to support manufacture of Novavax' COVID-19 vaccine

Novavax, Inc. (Nasdaq: NVAX), a biotechnology company developing next-generation vaccines for serious infectious diseases, GSK and the […]

  1. Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
  2. Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
  3. DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
  4. Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
  5. Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more